The present study’s findings are notable in that CL treatment led to significant reductions not only in MMP expression but also in TNF-α and IL-6 levels, supporting its dual role in modulating both immune activation and the inflammatory cascade involved in aneurysm pathophysiology. This evidence concerns the gene IL6 and aneurysm.